MA28553B1 - 2 - {[2- (2-METHYLAMINO-PYRIMIDIN-4-YL) -1H-INDOLE-5-CARBONYL] -AMINE} -3- (PHENYLPYRIDIN-2-YL-AMINO) -PURSTIC ACID SUBSTANTIALLY PURE AS A KINASE INHIBITOR IKB - Google Patents

2 - {[2- (2-METHYLAMINO-PYRIMIDIN-4-YL) -1H-INDOLE-5-CARBONYL] -AMINE} -3- (PHENYLPYRIDIN-2-YL-AMINO) -PURSTIC ACID SUBSTANTIALLY PURE AS A KINASE INHIBITOR IKB

Info

Publication number
MA28553B1
MA28553B1 MA29415A MA29415A MA28553B1 MA 28553 B1 MA28553 B1 MA 28553B1 MA 29415 A MA29415 A MA 29415A MA 29415 A MA29415 A MA 29415A MA 28553 B1 MA28553 B1 MA 28553B1
Authority
MA
Morocco
Prior art keywords
purstic
phenylpyridin
pyrimidin
methylamino
indole
Prior art date
Application number
MA29415A
Other languages
French (fr)
Inventor
El-Bdaoui Haddad
Olaf Ritzeler
David J Aldous
Paul Joseph Cox
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of MA28553B1 publication Critical patent/MA28553B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • AIDS & HIV (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA29415A 2004-05-12 2006-10-27 2 - {[2- (2-METHYLAMINO-PYRIMIDIN-4-YL) -1H-INDOLE-5-CARBONYL] -AMINE} -3- (PHENYLPYRIDIN-2-YL-AMINO) -PURSTIC ACID SUBSTANTIALLY PURE AS A KINASE INHIBITOR IKB MA28553B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57014604P 2004-05-12 2004-05-12

Publications (1)

Publication Number Publication Date
MA28553B1 true MA28553B1 (en) 2007-04-03

Family

ID=34969825

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29415A MA28553B1 (en) 2004-05-12 2006-10-27 2 - {[2- (2-METHYLAMINO-PYRIMIDIN-4-YL) -1H-INDOLE-5-CARBONYL] -AMINE} -3- (PHENYLPYRIDIN-2-YL-AMINO) -PURSTIC ACID SUBSTANTIALLY PURE AS A KINASE INHIBITOR IKB

Country Status (23)

Country Link
EP (1) EP1747215A1 (en)
JP (1) JP2007537266A (en)
KR (1) KR20070011483A (en)
CN (1) CN1950359A (en)
AR (1) AR049274A1 (en)
AU (1) AU2005245834A1 (en)
BR (1) BRPI0511029A (en)
CA (1) CA2566213A1 (en)
EC (1) ECSP066992A (en)
GT (1) GT200500111A (en)
IL (1) IL178992A0 (en)
MA (1) MA28553B1 (en)
MX (1) MXPA06012870A (en)
NO (1) NO20065719L (en)
PA (1) PA8633101A1 (en)
PE (1) PE20060269A1 (en)
RU (1) RU2006143758A (en)
SV (1) SV2006002111A (en)
TN (1) TNSN06338A1 (en)
TW (1) TW200605881A (en)
UY (1) UY28897A1 (en)
WO (1) WO2005113544A1 (en)
ZA (1) ZA200608712B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19951360A1 (en) 1999-10-26 2001-05-03 Aventis Pharma Gmbh Substituted indoles
DE102004033406A1 (en) * 2004-07-10 2006-02-16 Sanofi-Aventis Deutschland Gmbh Process for the preparation of the enantiomeric forms of 2,3-diaminopropionic acid derivatives
EP2025674A1 (en) 2007-08-15 2009-02-18 sanofi-aventis Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs
US11969501B2 (en) 2008-04-21 2024-04-30 Dompé Farmaceutici S.P.A. Auris formulations for treating otic diseases and conditions
KR20190026056A (en) 2008-04-21 2019-03-12 오토노미, 인코포레이티드 Auris formulations for treating otic diseases and conditions
WO2011107494A1 (en) 2010-03-03 2011-09-09 Sanofi Novel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof
BR112012027542A2 (en) * 2010-04-27 2019-09-24 Hutchison Medipharma Ltd pyrimidinyl indole indole compounds
EP2582709B1 (en) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
US8828995B2 (en) 2011-03-08 2014-09-09 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8710050B2 (en) 2011-03-08 2014-04-29 Sanofi Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120052A1 (en) 2011-03-08 2012-09-13 Sanofi Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
EP2683705B1 (en) 2011-03-08 2015-04-22 Sanofi Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683700B1 (en) 2011-03-08 2015-02-18 Sanofi Tetra-substituted oxathiazine derivatives, method for their preparation, their usage as medicament and medicament containing same and its use
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
CN109689027A (en) 2016-06-29 2019-04-26 奥德纳米有限公司 Triglycerides aural preparations and application thereof
CN106588803A (en) * 2016-11-16 2017-04-26 西南科技大学 Novel method for preparing 5-acetylisoxazole

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10237722A1 (en) * 2002-08-17 2004-08-19 Aventis Pharma Deutschland Gmbh Indole or benzimidazole derivatives for the modulation of IKappaB kinase

Also Published As

Publication number Publication date
RU2006143758A (en) 2008-06-27
MXPA06012870A (en) 2007-02-15
BRPI0511029A (en) 2007-11-27
GT200500111A (en) 2006-05-09
AU2005245834A1 (en) 2005-12-01
TNSN06338A1 (en) 2008-02-22
AR049274A1 (en) 2006-07-12
KR20070011483A (en) 2007-01-24
NO20065719L (en) 2006-12-12
TW200605881A (en) 2006-02-16
CN1950359A (en) 2007-04-18
JP2007537266A (en) 2007-12-20
CA2566213A1 (en) 2005-12-11
WO2005113544A1 (en) 2005-12-01
SV2006002111A (en) 2006-01-30
EP1747215A1 (en) 2007-01-31
PA8633101A1 (en) 2006-01-23
UY28897A1 (en) 2005-12-30
PE20060269A1 (en) 2006-05-11
ECSP066992A (en) 2006-12-29
ZA200608712B (en) 2008-06-25
IL178992A0 (en) 2007-03-08

Similar Documents

Publication Publication Date Title
MA28553B1 (en) 2 - {[2- (2-METHYLAMINO-PYRIMIDIN-4-YL) -1H-INDOLE-5-CARBONYL] -AMINE} -3- (PHENYLPYRIDIN-2-YL-AMINO) -PURSTIC ACID SUBSTANTIALLY PURE AS A KINASE INHIBITOR IKB
IL194424A0 (en) 4-anilinoquinoline-3-carboxamides as csf-1r kinase inhibitors
EP1951715A4 (en) Aminopyrimidines useful as kinase inhibitors
EP2005957A4 (en) Acid secretion inhibitor
HK1200164A1 (en) Heterodimers of glutamic acid
ZA200806017B (en) Pyrimidine deivatives used as pi-3 kinase inhibitors
PL2079727T3 (en) Kinase inhibitor compounds
IL193653A0 (en) Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors
IL200898A0 (en) Pyrimidine hydrazide compounds as pgds inhibitors
ZA200802222B (en) Pyrimidine amide compounds as PGDS inhibitors
HRP20130004T8 (en) 4-substituted phenoxyphenylacetic acid derivatives
DK2283024T3 (en) 4-aryl-2-aniline pyrimidines as PLK kinase inhibitors
HK1117504A1 (en) Benzimidazole thiophene compounds as plk inhibitors
PL1703019T3 (en) Phosphoric acid stabilized creping adhesive
EP1778693A4 (en) Tricyclic-heteroaryl compounds useful as kinase inhibitors
DK1910267T3 (en) Process for the preparation of carboxylic acid alkyl esters
ZA200809557B (en) 2-(pyridin-2-yl)-pyrimidines for use as fungicides
IL197327A0 (en) Crystalline rosuvastatin calcium
BRPI0811597A2 (en) pyrimidone arylamide compounds
DK2225198T3 (en) Process for the preparation of a substituted gamma-amino acid
ZA200709852B (en) Spiro-benzimidazoles as inhibitors of gastric acid secretion
GB0619494D0 (en) Chiral phosphorus compound
DK2010538T3 (en) Process for Preparing [(1R), 2S] -2-Aminopropionic Acid 2- [4- (4-Fluoro-2-methyl-1H-indol-5-yloxy) -5-methylpyrrole] 2,1-f- [1 , 2,4-triazin-6-yloxy] -1-methylethyl ester
ZA200905263B (en) Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors
ZA200806859B (en) Novel crystalline compounds